2675 — Shenzhen Edge Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$23.09bn
- HK$22.09bn
- CNY159.99m
Annual cashflow statement for Shenzhen Edge Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -213 | -219 |
| Depreciation | ||
| Amortisation | ||
| Non-Cash Items | -61.8 | 9.44 |
| Unusual Items | ||
| Equity in Net Earnings/Losses | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -64.5 | -43.8 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Payable / Accrued Expenses | ||
| Change in Other Liabilities | ||
| Cash from Operating Activities | -320 | -225 |
| Capital Expenditures | -63.6 | -27 |
| Purchase of Fixed Assets | ||
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | 447 | 223 |
| Sale of Fixed Assets | ||
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 384 | 196 |
| Financing Cash Flow Items | -1.8 | -0.376 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -9.18 | -7.34 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 54.5 | -35.5 |